Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 08, 2022

BUY
$168.19 - $186.01 $275,158 - $304,312
1,636 New
1,636 $290,000
Q1 2022

Apr 12, 2022

SELL
$158.14 - $179.59 $98,995 - $112,423
-626 Closed
0 $0
Q4 2021

Jan 18, 2022

BUY
$155.93 - $173.01 $3,898 - $4,325
25 Added 4.16%
626 $107,000
Q3 2021

Oct 18, 2021

SELL
$161.5 - $179.47 $762,764 - $847,636
-4,723 Reduced 88.71%
601 $97,000
Q2 2021

Jul 16, 2021

BUY
$159.48 - $171.07 $810,955 - $869,890
5,085 Added 2127.62%
5,324 $877,000
Q1 2021

Apr 09, 2021

BUY
$153.07 - $170.48 $36,583 - $40,744
239 New
239 $39,000
Q4 2020

Jan 11, 2021

SELL
$137.11 - $157.38 $39,350 - $45,168
-287 Closed
0 $0
Q3 2020

Oct 23, 2020

SELL
$140.38 - $153.83 $943,213 - $1.03 Million
-6,719 Reduced 95.9%
287 $43,000
Q2 2020

Jul 13, 2020

BUY
$128.81 - $155.51 $454,312 - $548,483
3,527 Added 101.38%
7,006 $1.04 Million
Q1 2020

Apr 14, 2020

BUY
$111.14 - $153.99 $385,433 - $534,037
3,468 Added 31527.27%
3,479 $456,000
Q4 2019

Jan 31, 2020

SELL
$127.5 - $146.44 $250,410 - $287,608
-1,964 Reduced 99.44%
11 $2,000
Q3 2019

Oct 15, 2019

SELL
$126.95 - $142.14 $199,692 - $223,586
-1,573 Reduced 44.33%
1,975 $256,000
Q2 2019

Jul 18, 2019

BUY
$131.15 - $144.24 $450,893 - $495,897
3,438 Added 3125.45%
3,548 $494,000
Q1 2019

Apr 11, 2019

BUY
$125.72 - $139.79 $1,382 - $1,537
11 Added 11.11%
110 $15,000
Q4 2018

Jan 22, 2019

BUY
$122.84 - $147.84 $12,161 - $14,636
99 New
99 $13,000
Q3 2018

Oct 23, 2018

SELL
$121.58 - $142.88 $640,483 - $752,691
-5,268 Closed
0 $0
Q2 2018

Aug 01, 2018

BUY
$119.4 - $131.76 $95,639 - $105,539
801 Added 17.93%
5,268 $639,000
Q1 2018

May 02, 2018

SELL
$125.1 - $148.14 $50,040 - $59,255
-400 Reduced 8.22%
4,467 $569,000
Q4 2017

Feb 07, 2018

BUY
$131.22 - $143.62 $638,647 - $698,998
4,867
4,867 $680,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Nu Wave Investment Management, LLC Portfolio

Follow Nu Wave Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nu Wave Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nu Wave Investment Management, LLC with notifications on news.